World Health Expo 2026 highlights the Middle East’s ambition to become a global biotech hub
Dubai, UAE — The global biotechnology industry is expanding rapidly, and the Middle East aims to become a key player. At the World Health Expo (WHX) 2026 in Dubai, organisers launched a dedicated Biotech & Life Sciences Zone, highlighting the region’s growing ambition to position itself as a global hub for medical innovation.
The event at the Dubai Exhibition Centre attracted over 235,000 professional visits and more than 4,300 exhibitors, making it one of the largest healthcare gatherings worldwide.
A Fast-Growing Global Market
Biotechnology uses biological systems, cells and genetic processes to develop new medical treatments, diagnostics and production technologies. The sector is currently accelerating due to advances in AI-driven research, precision medicine and new therapeutic platforms.
The market is expanding at an extraordinary pace. According to Global Data Route Analytics, biotechnology was valued at $1.6 trillion in 2020 and could grow to $4 trillion by 2035, with annual growth rates above 14 percent.
For entrepreneurs and investors, the opportunity lies in multiple areas:
- genomics and precision medicine
- oncology and rare disease research
- synthetic biology
- AI-supported drug discovery
The Middle East Is Scaling Its Biotech Ambitions
The Gulf region is increasing investment in life sciences. A Knight Frank report projects the GCC biotechnology market will reach $2.6 billion by 2028, driven mainly by the UAE and Saudi Arabia.
The United Arab Emirates in particular is positioning itself as a global centre for biotechnology, pharmaceutical manufacturing and precision medicine. Government initiatives such as Operation 300Bn — a programme allocating AED 300 billion to industrial sectors — are accelerating research, investment and international collaboration.
For founders and investors, the region offers a growing ecosystem that connects research institutions, healthcare providers and global capital.
From Research to Real-World Healthcare Innovation
The new Biotech & Life Sciences Zone at WHX will bring together scientists, investors and policymakers to discuss how biotechnology can move faster from lab research to scalable healthcare solutions.
Dr. Omar Najim, CEO of Baynouna Gene Solutions and Adjunct Clinical Associate Professor at Khalifa University, sees the region playing a strategic role: “The Middle East can act as a bridge between scientific discovery and real-world healthcare transformation”, he says.
Key sessions at the event focussed on:
- the future of AI-driven life science research
- investment strategies in biotech innovation
- global collaboration in cell and gene therapy
- the role of biotechnology in health, sustainability and food systems
The conference concluded with a keynote by Andrew Craig, author of The Future Is Biotech, on the long-term impact of biotechnology on global health.
A Global Healthcare Platform
WHX 2026 took place alongside WHX Labs, the region’s leading diagnostics and laboratory medicine event. Held under the patronage of the UAE Ministry of Health and Prevention, the event underscores the country’s strategy to become a leading international hub for biotechnology and life sciences innovation.
For entrepreneurs in healthcare, biotech and investment, the message is clear: the next wave of biotech growth is not only happening in traditional hubs. It is increasingly emerging in the Middle East.
